Sano Hitomi, Izumida Michiko, Shimizu Hiroshi, Ogawa Yunosuke
Department of Paediatrics, Saitama Medical Centre, Saitama Medical School, Kawagoe, Japan.
Eur J Pediatr. 2002 Apr;161(4):196-201. doi: 10.1007/s00431-002-0922-z.
Risk factors of renal involvement and significant proteinuria in patients with Henoch-Schönlein purpura (HSP) were retrospectively evaluated by univariate and multivariate analyses. The analysis was performed in 134 patients with HSP. Renal involvement was found in 65 patients (49%) and 97% of the renal involvement was found within 3 months of disease onset. Moderate or severe proteinuria was recognised in 25 patients. A univariate analysis revealed that an age of more than 4 years at the onset, severe abdominal pain with gastrointestinal bleeding, persistent purpura over a month, coagulation factor XIII activity < 80%, and treatment with factor XIII concentrate were associated with developing renal involvement. A multivariate analysis showed that severe abdominal symptoms, an age of more than 4 years, and persistent purpura increased the risk of renal involvement. Risk factors of moderate or severe proteinuria were also examined. The risk factors in a univariate analysis were severe abdominal symptoms, persistent purpura, decreased factor XIII activity, treatment with steroids, and treatment with factor XIII concentrate. Of those, persistent purpura, treatment with factor XIII concentrate, and factor XIII activity < 80% were associated with significant proteinuria in a multivariate analysis. Among the patients with severe abdominal symptoms, factor XIII activity was significantly decreased in patients with significant proteinuria compared to other patients without significant proteinuria.
Long-term prognosis of Henoch-Schönlein purpura is dependent on the severity of renal involvement. In those patients who have the risk factors of renal involvement, especially significant proteinuria, close attention should be paid to a urinalysis for at least 3 months from the onset of the disease.
通过单因素和多因素分析对过敏性紫癜(HSP)患者肾脏受累及显著蛋白尿的危险因素进行回顾性评估。对134例HSP患者进行了分析。65例(49%)患者出现肾脏受累,其中97%的肾脏受累发生在疾病发作后3个月内。25例患者出现中度或重度蛋白尿。单因素分析显示,发病年龄超过4岁、伴有胃肠道出血的严重腹痛、紫癜持续超过1个月、凝血因子 XIII 活性<80%以及使用凝血因子 XIII 浓缩物治疗与肾脏受累的发生相关。多因素分析表明,严重腹部症状、年龄超过4岁和紫癜持续存在会增加肾脏受累的风险。还研究了中度或重度蛋白尿的危险因素。单因素分析中的危险因素为严重腹部症状、紫癜持续存在、凝血因子 XIII 活性降低、使用类固醇治疗以及使用凝血因子 XIII 浓缩物治疗。其中,紫癜持续存在、使用凝血因子 XIII 浓缩物治疗以及凝血因子 XIII 活性<80%在多因素分析中与显著蛋白尿相关。在有严重腹部症状的患者中,与其他无显著蛋白尿的患者相比,有显著蛋白尿的患者凝血因子 XIII 活性显著降低。
过敏性紫癜的长期预后取决于肾脏受累的严重程度。对于那些有肾脏受累危险因素,尤其是显著蛋白尿的患者,应从疾病发作起至少3个月密切关注尿液分析。